Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Iliac Stent Market, by Artery Lesions
1.4.2 Europe Iliac Stent Market, by End-use
1.4.3 Europe Iliac Stent Market, by Type
1.4.4 Europe Iliac Stent Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Opportunities
3.2.3 Market Restraints
3.2.4 Market Challenges
3.3 Porter’s Five Forces Analysis
Chapter 4. Europe Iliac Stent Market by Artery Lesions
4.1 Europe Common Iliac Artery Lesions Market by Country
4.2 Europe Severe Calcified Lesions Market by Country
4.3 Europe Complete Obstructive Lesions Market by Country
Chapter 5. Europe Iliac Stent Market by End-use
5.1 Europe Hospitals Market by Country
5.2 Europe Outpatient Facilities Market by Country
5.3 Europe Others Market by Country
Chapter 6. Europe Iliac Stent Market by Type
6.1 Europe Self-expandable Stents Market by Country
6.2 Europe Balloon-expandable Stents Market by Country
6.3 Europe Others Market by Country
Chapter 7. Europe Iliac Stent Market by Country
7.1 Germany Iliac Stent Market
7.1.1 Germany Iliac Stent Market by Artery Lesions
7.1.2 Germany Iliac Stent Market by End-use
7.1.3 Germany Iliac Stent Market by Type
7.2 UK Iliac Stent Market
7.2.1 UK Iliac Stent Market by Artery Lesions
7.2.2 UK Iliac Stent Market by End-use
7.2.3 UK Iliac Stent Market by Type
7.3 France Iliac Stent Market
7.3.1 France Iliac Stent Market by Artery Lesions
7.3.2 France Iliac Stent Market by End-use
7.3.3 France Iliac Stent Market by Type
7.4 Russia Iliac Stent Market
7.4.1 Russia Iliac Stent Market by Artery Lesions
7.4.2 Russia Iliac Stent Market by End-use
7.4.3 Russia Iliac Stent Market by Type
7.5 Spain Iliac Stent Market
7.5.1 Spain Iliac Stent Market by Artery Lesions
7.5.2 Spain Iliac Stent Market by End-use
7.5.3 Spain Iliac Stent Market by Type
7.6 Italy Iliac Stent Market
7.6.1 Italy Iliac Stent Market by Artery Lesions
7.6.2 Italy Iliac Stent Market by End-use
7.6.3 Italy Iliac Stent Market by Type
7.7 Rest of Europe Iliac Stent Market
7.7.1 Rest of Europe Iliac Stent Market by Artery Lesions
7.7.2 Rest of Europe Iliac Stent Market by End-use
7.7.3 Rest of Europe Iliac Stent Market by Type
Chapter 8. Company Profiles
8.1 Becton, Dickinson, and Company
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Trials and Approvals:
8.1.6 SWOT Analysis
8.2 Abbott Laboratories
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 SWOT Analysis
8.3 Boston Scientific Corporation
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Trials and Approvals:
8.3.6 SWOT Analysis
8.4 W. L. Gore & Associates, Inc.
8.4.1 Company Overview
8.4.2 SWOT Analysis
8.5 Medtronic PLC
8.5.1 Company overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expenses
8.5.5 Recent strategies and developments:
8.5.5.1 Trials and Approvals:
8.5.6 SWOT Analysis
8.6 Cook Medical, Inc. (Cook Group)
8.6.1 Company Overview
8.6.2 SWOT Analysis
8.7 Terumo Corporation
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expenses
8.7.5 Recent strategies and developments:
8.7.5.1 Trials and Approvals:
8.7.5.2 Product Launches and Product Expansions:
8.7.6 SWOT Analysis
8.8 iVascular S.L.U.
8.8.1 Company Overview
8.8.2 SWOT Analysis
8.9 Getinge AB
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expense
8.9.5 Recent strategies and developments:
8.9.5.1 Trials and Approvals:
8.9.6 SWOT Analysis
8.10. Biotronik SE & Co. KG
8.10.1 Company Overview
8.10.2 SWOT Analysis
Unique Offerings 